Indication
Postinflammatory Hyperpigmentation
1 clinical trial
2 products
Clinical trial
Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne VulgarisStatus: Withdrawn, Estimated PCD: 2022-01-09
Product
Tranexamic AcidProduct
Vehicle